FTI Survey Reveals Optimism in Healthcare and Life Sciences for 2025

FTI Consulting’s U.S. Healthcare and Life Sciences Industry Outlook 2025 reveals a growing sense of optimism within the sector, with 79% of leaders expressing confidence in the industry’s financial outlook, an 11% increase from the previous year. The survey, which included 250 decision-makers, also shows a significant rise in expectations for

Become a Member

Members have access to all articles.

Membership
mergers and acquisitions, with 66% of leaders predicting higher activity in 2025. This renewed optimism is fueled by investment in areas such as obesity treatments, immuno-oncology, gene editing, and AI-powered drug discovery. Additionally, 40% of respondents foresee a greater ability to raise capital, marking a 10% increase from last year.

However, the industry faces challenges, with 38% economic uncertainty and 23% cybersecurity risks as the primary concerns. Political uncertainty has also gained prominence, particularly in light of the potential implications of the U.S. presidential election. The survey indicates that nearly 60% of leaders anticipate a positive impact on their business from a second Trump administration. FTI Consulting suggests that industry leaders should prepare for regulatory changes, a more favorable deal-making environment, and increased competition, while also strengthening political relationships to navigate potential shifts in policy.

Read more